Randomized controlled trial finds no significant weight or metabolic health changes in HIV and obesity patients after switching regimens.
In people with HIV and obesity, switching from an INSTI+TAF/FTC regimen to DOR/FTC with either TAF or TDF did not produce clinically meaningful differences in weight change or metabolic health after 48 weeks.
No takes yet. Share an insight, caveat, or question.
Koethe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: